KIAA1524 Antikörper (AA 269-301)
Kurzübersicht für KIAA1524 Antikörper (AA 269-301) (ABIN7479944)
Target
Alle KIAA1524 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 269-301
-
Verwendungszweck
- CIP2A Antibody / p90 Autoantigen (N-Terminal Region)
-
Aufreinigung
- Antigen affinity
-
Immunogen
- A portion of amino acids 269-301 from the human protein was used as the immunogen for the CIP2A antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Titration of the CIP2A antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the CIP2A antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- KIAA1524
-
Andere Bezeichnung
- CIP2A
-
Hintergrund
- Cancerous Inhibitor of Protein Phosphatase 2A is an oncoprotein that inhibits PP2A and stabilizes MYC in human malignancies. Promotes anchorage-independent cell growth and tumor formation.
-
UniProt
- Q8TCG1
Target
-